EIAV, CAEV and other lentivirus vector systems

Somatic Cell and Molecular Genetics

Volumn 26, Issue 1-6, 2001, Pages 131-145

  Olsen, John C ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR;

CAPRINE ARTHRITIS ENCEPHALITIS VIRUS; EQUINE INFECTIOUS ANEMIA VIRUS; GENE FUNCTION; GENE TRANSFER; HUMAN IMMUNODEFICIENCY VIRUS; JEMBRANA DISEASE VIRUS; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS; VIRUS GENE; VISNA VIRUS;

CAPRA; CAPRINE ARTHRITIS-ENCEPHALITIS VIRUS; EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; JEMBRANA DISEASE VIRUS; LENTIVIRUS; PRIMATES; RNA VIRUSES; VISNA VIRUS;

EID: 0035525967     PISSN: 07407750     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021030830943     Document Type: Review

References (66)

1. Naldini L, Verma IM. Lentiviral vectors. Adv Virus Res 2000; 55:599-609.
2. Schiltz RL, Shih DS, Rasty S et al. Equine infectious anemia virus gene expression: Characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2. J Virol 1992; 66(6):3455-3465.
3. Chadwick BJ, Coelen RJ, Wilcox GE et al. Nucleotide sequence analysis of Jembrana disease virus: A bovine lentivirus associated with an acute disease syndrome. J Gen Virol 1995; 76(Pt 7):1637-1650.
4. Maury W. Regulation of equine infectious anemia virus expression. J Biomed Sci 1998; 5(1):11-23.
5. Li F, Leroux C, Craigo JK et al. The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies. J Virol 2000; 74(1):573-579.
6. Li F, Puffer BA, Montelaro RC. The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro. J Virol 1998; 72(10):8344-8348.
7. Elder JH, Lerner DL, Hasselkus-Light CS et al. Distinct subsets of retroviruses encode dUTPase. J Virol 1992; 66(3):1791-1794.
8. Abergel C, Robertson DL, Claverie JM. "Hidden" dUTPase sequence in human immunodeficiency virus type 1 gp120. J Virol 1999; 73(1):751-753.
9. Bergman AC, Bjornberg O, Nord J et al. The protein p30, encoded at the gag-pro junction of mouse mammary tumor virus, is a dUTPase fused with a nucleocapsid protein. Virology 1994; 204(1):420-424.
10. Koppe B, Menendez-Arias L, Oroszlan S. Expression and purification of the mouse mammary tumor virus gag-pro transframe protein p30 and characterization of its dUTPase activity. J Virol 1994; 68(4):2313-2319.
11. Caradonna SJ, Cheng YC. Induction of uracil-DNA glycosylase and dUTP nucleotidohydrolase activity in herpes simplex virus-infected human cells. J Biol Chem 1981; 256(19):9834-9837.
12. Broyles SS. Vaccinia virus encodes a functional dUTPase. Virology 1993; 195(2):863-865.
13. Baldo AM, McClure MA. Evolution and horizontal transfer of dUTPase-encoding genes in viruses and their hosts. J Virol 1999; 73(9):7710-7721.
14. Vassylyev DG, Morikawa K. Precluding uracil from DNA. Structure 1996; 4(12):1381-1385.
15. Richards RG, Sowers LC, Laszlo J et al. The occurrence and consequences of deoxyuridine in DNA. Adv Enzyme Regul 1984; 22:157-185.
16. Hokari S, Horikawa S, Tsukada K et al. Expression of deoxyuridine triphosphatase during liver regeneration in rat. Biochem Mol Biol Int 1995; 37(3):583-590.
17. Pang JH, Chen KY. Global change of gene expression at late G1/S boundary may occur in human IMR-90 diploid fibroblasts during senescence. J Cell Physiol 1994; 160(3):531-538.
18. Spector R, Boose B. Development and regional distribution of deoxyuridine 5′-triphosphatase in rabbit brain. J Neurochem 1983; 41(4):1192-1195.
19. Strahlet JR, Zhu XX, Hora N et al. Maturation stage and proliferation-dependent expression of dUTPase in human T cells. Proc Natl Acad Sci USA 1993; 90(11):4991-4995.
20. Sugita Y, Yamauchi H, Omine M et al. Elevated deoxyuridine triphosphate nucleotidohydrolase (dUTPase) activity in the cobalamin-deficient megaloblastic bone marrow cells. Int J Hematol 1996; 64(3-4):203-212.
21. Vilpo JA. Mitogen induction of deoxyuridine triphosphatase activity in human T and B lymphocytes. Med Biol 1983; 61(1):54-58.
22. Wagaman PC, Hasselkus-Light CS, Henson M et al. Molecular cloning and characterization of deoxyuridine triphosphatase from feline immunodeficiency virus (FIV). Virology 1993; 196(2):451-457.
23. Threadgill DS, Steagall WK, Flaherty MT et al. Characterization of equine infectious anemia virus dUTPase: Growth properties of a dUTPase-deficient mutant. J Virol 1993; 67(5):2592-2600.
24. Lichtenstein DL, Rushlow KE, Cook RF et al. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. J Virol 1995; 69(5):2881-2888.
25. Turelli P, Petursson G, Guiguen F et al. Replication properties of dUTPase-deficient mutants of caprine and ovine lentiviruses. J Virol 1996; 70(2):1213-1217.
26. Petursson G, Turelli P, Matthiasdottir S et al. Visna virus dUTPase is dispensable for neuropathogenicity. J Virol 1998; 72(2):1657-1661.
27. Turelli P, Guiguen F, Mornex JF et al. dUTPase-minus caprine arthritis-encephalitis virus is attenuated for pathogenesis and accumulates G-to-A substitutions. J Virol 1997; 71(6):4522-4530.
28. Lerner DL, Wagaman PC, Phillips TR et al. Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyutidine-triphosphatase. Proc Natl Acad Sci USA 1995; 92(16):7480-7484.
29. Phillips TR, Prospero-Garcia O, Wheeler DW et al. Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. J Neurovirol 1996; 2(6):388-396.
30. Steagall WK, Robek MD, Perry ST et al. Incorporation of uracil into viral DNA correlates with reduced replication of EIAV in macrophages. Virology 1995; 210(2):302-313.
31. Campbell RS, Robinson WF. The comparative pathology of the lentiviruses. J Comp Pathol 1998; 119(4):333-395.
32. Issel CJ, Coggins L. Equine infectious anemia: Current knowledge. J Am Vet Med Assoc 1979; 174(7):727-733.
33. Montelaro RC, Cole KS, Hammond SA. Maturation of immune responses to lentivirus infection: Implications for AIDS vaccine development. AIDS Res Hum Retroviruses 1998; 14 Suppl 3:S255-S259.
34. Payne SL, Qi X-M, Shao H et al. Disease induction by virus derived from molecular clones of equine infectious anemia virus. J Virol 1998; 72:483-487.
35. Cook RF, Leroux C, Cook SJ et al. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. J Virol 1998; 72:1383-1393.
36. Belshan M, Baccam P, Oaks JL et al. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony. Virology 2001; 279(1):185-200.
37. Olsen JC. Gene transfer vectors derived from equine infectious anemia virus. Gene Therapy 1998; 5:1481-1487.
38. Mitrophanous K, Yoon S, Rohll J et al. Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther 1999; 6(11):1808-18.
39. Maury W. Monocyte maturation controls expression of equine infectious anemia virus. J Virol 1994; 68(10):6270-6279.
40. Sellon DC, Walker KM, Russell KE et al. Equine infectious anemia virus replication is upregulated during differentiation of blood monocytes from acutely infected horses. J Virol 1996; 70(1):590-594.
41. Maury W, Oaks JL, Bradley S. Equine endothelial cells support productive infection of equine infectious anemia virus. J Virol 1998; 72(11):9291-9297.
42. Bowles NE, Eisensmith RC, Mohuiddin R et al. A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo. Hum Gene Ther 1996; 7(14):1735-1742.
43. Johnson LG, Mewshaw JP, Ni H et al. Effect of host modification and age on airway epithelial gene transfer mediated by a murine leukemia virus-derived vector. J Virol 1998; 72:8861-8872.
44. Yamada K, Olsen JC, Patel M et al. Functional correction of Fanconi anemia group C (FANCC) hematopoietic cells by the use of a novel lentiviral vector. Mol Therapy 2001; 3(4):485-490.
45. Gush KA, Fu KL, Grompe M et al. Phenotypic correction of Fanconi anemia group C knockout mice. Blood 2000; 95(2):700-704.
46. Liu JM, Kim S, Read EJ et al. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Hum Gene Ther 1999; 10(14):2337-2346.
47. Pepin M, Vitu C, Russo P et al. Maedi-visna virus infection in sheep: A review. Vet Res 1998; 29(3-4):341-367.
48. Georgsson G. Neuropathologic aspects of lentiviral infections. Ann NY Acad Sci 1994; 724:50-67.
49. Carey N, Dalziel RG. The biology of maedi-visna virus - An overview. Bt Vet J 1993; 149(5):437-454.
50. Clements JE, Zink MC, Narayan O et al. Lentivirus infection of macrophages. Immunol Set 1994; 60:589-600.
51. Zink MC, Narayan O, Kennedy PG et al. Pathogenesis of visna/maedi and caprine arthritis-encephalitis: New leads on the mechanism of restricted virus replication and persistent inflammation. Vet Immunol Immunopathol 1987; 15(1-2):167-80.
52. Gendelman HE, Narayan O, Kennedy-Stoskopf S et al. Tropism of sheep lentiviruses for monocytes: Susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol 1986; 58(1):67-74.
53. Narayan O, Kennedy-Stoskopf S, Sheffer D et al. Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect Immun 1983; 41(1):67-73.
54. Mselli-Lakhal L, Favier C, Da Silva Teixeira MF et al. Defective RNA packaging is responsible for low transduction efficiency of CAEV-based vectors. Arch Virol 1998; 143(4):681-695.
55. Berkowitz RD, Ilves H, Plavec I et al. Gene transfer systems derived from Visna virus: Analysis of virus production and infectivity. Virology 2001; 279(1):116-129.
56. Straub OC, Levy D. Bovine immunodeficiency virus and analogies with human immunodeficiency virus. Leukemia 1999; 13 Suppl 1:S106-9.
57. Wilcox GE, Chadwick BJ, Kertayadnya G. Recent advances in the understanding of Jembrana disease. Vet Microbiol 1995; 46(1-3):249-255.
58. Hartaningsih N, Wilcox GE, Dharma DM et al. Distribution of Jembrana disease in cattle in Indonesia. Vet Microbiol 1993; 38(1-2):23-29.
59. Dharma DM, Budiantono A, Campbell RS et al. Studies on experimental Jembrana disease in Bali cattle. III. Pathology. J Comp Pathol 1991; 105(4):397-414.
60. Chadwick BJ, Desport M, Brownlie J et al. Detection of Jembrana disease virus in spleen, lymph nodes, bone marrow and other tissues by in situ hybridization of paraffin-embedded sections. J Gen Virol 1998; 79(Pt 1):101-106.
61. Soeharsono S, Hartaningsih N, Soetrisno M et al. Studies of experimental Jembrana disease in Bali cattle. I. Transmission and persistence of the infectious agent in ruminants and pigs, and resistance of recovered cattle to re-infection. J Comp Pathol 1990; 103(1):49-59.
62. Metharom P, Takyar S, Xia HH et al. Novel bovine lentiviral vectors based on Jembrana disease virus. J Gene Med 2000; 2(3):176-185.
63. Mselli-Lakhal L, Favier C, Leung K et al. Lack of functional receptors is the only barrier that prevents caprine arthritis-encephalitis virus from infecting human cells. J Virol 2000; 74(18):8343-8348.
64. Olsen JC, Patel M, Rohll JB et al. An inducible first generation stable packaging cell line for equine lentiviral vectors. Mol Therapy 2000; 1:S315 (Abstract 882).
65. Mitrophanous K, Ellard F, Slingsby J et al. Generation of an equine infectious anemia virus (EIAV)-based lentiviral producer cell line. Mol Therapy 2000; 1:S314 (Abstract 881).
66. Berkowitz R, Ilves H, Lin WY et al. Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus. J Virol 2001; 75:3371-82.